MK-1406
Unknown / undisclosed
Also known as CD388
Evidence outlook
Mid-stage studies underway, no completed readout
Phase 2 studies are registered but none has completed a readout, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
Featured-trial selection for this indication is pending.
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 3 (1)
What this study did
Phase 2 (3)
What this study did
What this study did
What this study did
Phase 1 (4)
What this study did
What this study did
What this study did
What this study did
Competitive landscape
This drug's own stage for Seasonal Influenza: Stage not on record. Competitors below are sorted furthest-along first.
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials | |
|---|---|---|---|---|---|---|
| MK-1406: this drug | Stage not on record | Undisclosed | — | not yet graded | No reviewed efficacy summary in this indication | |
| GSK4382276 | —(overall) | Vaccine | — | not yet graded | No reviewed efficacy summary in this indication | |
| GSK5475152 | —(overall) | Vaccine | — | not yet graded | No reviewed efficacy summary in this indication | |
| PF-07252220 | —(overall) | Vaccine | — | not yet graded | No reviewed efficacy summary in this indication | |
| PF-07845104 | —(overall) | Vaccine | — | not yet graded | No reviewed efficacy summary in this indication | |
| PF-07926307 | —(overall) | Combination | — | not yet graded | No reviewed efficacy summary in this indication | |
| SP0287 | —(overall) | Combination | — | not yet graded | No reviewed efficacy summary in this indication |
Upcoming events
(4 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow MK-1406 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.